ALXN
ALXN Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Insiders
Institutions
Government
Income
Balance Sheet
Cash Flow
ALXN Income Statement
ALXN Balance Sheet
ALXN Cash Flow
Recent trades of ALXN by members of U.S. Congress
ALXN Stock Insider Trading Activity
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
ALXN Stock Institutional Owners
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
ALXN Derivatives Institutional Owners
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by ALXN's directors and management
Government lobbying spending instances
-
$40,000 Apr 26, 2022 Issue: Health Issues Medicare/Medicaid
-
$60,000 Apr 20, 2022 Issue: Health Issues
-
$50,000 Apr 15, 2022 Issue: Medicare/Medicaid Health Issues
-
$40,000 Jan 20, 2022 Issue: Health Issues
-
$50,000 Jan 20, 2022 Issue: None
-
$60,000 Jan 20, 2022 Issue: Health Issues
-
$70,000 Jan 19, 2022 Issue: Medicare/Medicaid Health Issues
-
$50,000 Jan 19, 2022 Issue: Budget/Appropriations Health Issues Taxation/Internal Revenue Code
-
$50,000 Jan 16, 2022 Issue: Health Issues Labor Issues/Antitrust/Workplace Medicare/Medicaid
-
$110,000 Oct 20, 2021 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Copyright/Patent/Trademark
-
$320,000 Jul 20, 2021 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark
-
$480,000 Apr 20, 2021 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark
-
$400,000 Jan 21, 2021 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark
-
$280,000 Oct 20, 2020 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark
-
$290,000 Jul 20, 2020 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark
-
$180,000 Apr 20, 2020 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark
-
$280,000 Apr 22, 2019 Issue: Medicare/Medicaid Health Issues
-
$292,809 Jan 17, 2019 Issue: Medicare/Medicaid Copyright/Patent/Trademark Health Issues Medical/Disease Research/Clinical Labs
-
$50,000 Jul 20, 2018 Issue: Health Issues Copyright/Patent/Trademark Medicare/Medicaid
-
$60,000 Jul 20, 2018 Issue: Medicare/Medicaid Health Issues
-
$361,497 Apr 19, 2018 Issue: Medicare/Medicaid Health Issues Trade (domestic/foreign) Taxation/Internal Revenue Code Copyright/Patent/Trademark Medical/Disease Research/Clinical Labs
-
$343,698 Jan 18, 2018 Issue: Trade (domestic/foreign) Taxation/Internal Revenue Code Copyright/Patent/Trademark Health Issues Medical/Disease Research/Clinical Labs Medicare/Medicaid
-
$275,000 Oct 16, 2017 Issue: Trade (domestic/foreign) Taxation/Internal Revenue Code Copyright/Patent/Trademark Health Issues Medicare/Medicaid Medical/Disease Research/Clinical Labs
-
$299,245 Jul 17, 2017 Issue: Health Issues Trade (domestic/foreign) Taxation/Internal Revenue Code Copyright/Patent/Trademark Medicare/Medicaid Medical/Disease Research/Clinical Labs
-
$308,894 Apr 20, 2017 Issue: Medical/Disease Research/Clinical Labs Medicare/Medicaid Health Issues Trade (domestic/foreign) Taxation/Internal Revenue Code Copyright/Patent/Trademark
-
$331,555 Jan 23, 2017 Issue: Health Issues Trade (domestic/foreign) Taxation/Internal Revenue Code Medicare/Medicaid
-
$300,000 Jan 12, 2016 Issue: Trade (domestic/foreign) Taxation/Internal Revenue Code Copyright/Patent/Trademark Health Issues
-
$300,000 Oct 18, 2015 Issue: Trade (domestic/foreign) Taxation/Internal Revenue Code Copyright/Patent/Trademark Health Issues
-
$300,000 Jul 17, 2015 Issue: Trade (domestic/foreign) Health Issues Taxation/Internal Revenue Code Copyright/Patent/Trademark
-
$300,000 Apr 17, 2015 Issue: Trade (domestic/foreign) Taxation/Internal Revenue Code Copyright/Patent/Trademark Health Issues
-
$285,000 Feb 09, 2015 Issue: Trade (domestic/foreign) Taxation/Internal Revenue Code Copyright/Patent/Trademark Health Issues
-
$250,000 Oct 20, 2014 Issue: Health Issues Taxation/Internal Revenue Code Copyright/Patent/Trademark
-
$285,000 Jul 21, 2014 Issue: Taxation/Internal Revenue Code Copyright/Patent/Trademark Health Issues
-
$285,000 Jul 21, 2014 Issue: Taxation/Internal Revenue Code Copyright/Patent/Trademark Health Issues
-
$275,000 Jan 21, 2014 Issue: Taxation/Internal Revenue Code Health Issues
-
$275,000 Oct 17, 2013 Issue: Trade (domestic/foreign) Taxation/Internal Revenue Code Health Issues
-
$225,000 Jul 15, 2013 Issue: Health Issues Trade (domestic/foreign) Taxation/Internal Revenue Code
-
$225,000 Apr 18, 2013 Issue: Health Issues Taxation/Internal Revenue Code
-
$360,000 Jan 09, 2013 Issue: Taxation/Internal Revenue Code Health Issues
-
$350,000 Oct 22, 2012 Issue: Trade (domestic/foreign) Health Issues Taxation/Internal Revenue Code
-
$350,000 Jul 19, 2012 Issue: Health Issues Trade (domestic/foreign)
-
$105,000 Apr 19, 2012 Issue: Health Issues Trade (domestic/foreign)
-
$105,000 Jan 19, 2012 Issue: Health Issues Trade (domestic/foreign)
-
$105,000 Oct 19, 2011 Issue: Trade (domestic/foreign) Health Issues
-
$105,000 Jul 20, 2011 Issue: Trade (domestic/foreign) Health Issues
-
$105,000 Apr 20, 2011 Issue: Health Issues
-
$100,000 Jan 20, 2011 Issue: Health Issues
-
$100,000 Oct 19, 2010 Issue: Health Issues
-
$100,000 Oct 19, 2010 Issue: Health Issues
-
$80,000 Apr 20, 2010 Issue: Health Issues
-
$80,000 Jan 19, 2010 Issue: Health Issues
-
$45,000 Oct 20, 2009 Issue: Health Issues
-
$45,000 Jul 20, 2009 Issue: Health Issues
-
$40,000 Apr 17, 2009 Issue: Health Issues
-
$20,000 Jan 22, 2009 Issue: Health Issues
Estimated quarterly lobbying spending
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
Government Contracts
Estimated quarterly amount awarded from public contracts
WallStreetBets
Number of mentions of ALXN in WallStreetBets Daily Discussion
ALXN News
Recent insights relating to ALXN
CNBC Recommendations
Recent picks made for ALXN stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in ALXN
ALXN Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view ALXN Smart Score
Score Breakdown
Bull Case vs Bear Case
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
Bulls Say:
The Bulls Say summary highlights positive aspects of the stock.
Bears Say:
The Bears Say summary points out potential risks and negative aspects of the stock.
Show More